IL238288B - Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome - Google Patents

Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome

Info

Publication number
IL238288B
IL238288B IL238288A IL23828815A IL238288B IL 238288 B IL238288 B IL 238288B IL 238288 A IL238288 A IL 238288A IL 23828815 A IL23828815 A IL 23828815A IL 238288 B IL238288 B IL 238288B
Authority
IL
Israel
Prior art keywords
pyrazolopyridazines
hearing loss
degenerative diseases
loss associated
usher syndrome
Prior art date
Application number
IL238288A
Other languages
English (en)
Hebrew (he)
Other versions
IL238288A0 (en
Original Assignee
Usher Iii Initiative Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usher Iii Initiative Inc filed Critical Usher Iii Initiative Inc
Publication of IL238288A0 publication Critical patent/IL238288A0/en
Publication of IL238288B publication Critical patent/IL238288B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL238288A 2012-10-25 2015-04-14 Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome IL238288B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718611P 2012-10-25 2012-10-25
US201361775402P 2013-03-08 2013-03-08
PCT/US2013/066939 WO2014066836A1 (en) 2012-10-25 2013-10-25 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome

Publications (2)

Publication Number Publication Date
IL238288A0 IL238288A0 (en) 2015-06-30
IL238288B true IL238288B (en) 2018-04-30

Family

ID=50545356

Family Applications (1)

Application Number Title Priority Date Filing Date
IL238288A IL238288B (en) 2012-10-25 2015-04-14 Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome

Country Status (10)

Country Link
EP (1) EP2911671B1 (enExample)
JP (1) JP6291502B2 (enExample)
AU (1) AU2013334139B2 (enExample)
CA (1) CA2889494C (enExample)
ES (1) ES2687854T3 (enExample)
HU (1) HUE039970T2 (enExample)
IL (1) IL238288B (enExample)
PL (1) PL2911671T3 (enExample)
WO (1) WO2014066836A1 (enExample)
ZA (1) ZA201502655B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5902293B2 (ja) 2011-04-25 2016-04-13 アッシャー・サード・イニシアティブ・インコーポレイテッド ピラゾロピリダジンおよび網膜変性疾患およびアッシャー症候群に伴う聴覚損失を治療するための方法
US9227976B2 (en) 2012-10-25 2016-01-05 Usher Iii Initiative, Inc. Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
JP6290910B2 (ja) * 2012-10-25 2018-03-07 アッシャー・サード・イニシアティブ・インコーポレイテッド ピラゾロピリダジンならびに網膜変性疾患およびアッシャー症候群に伴う聴力損失を処置するための方法
WO2017045955A1 (en) * 2015-09-14 2017-03-23 Basf Se Heterobicyclic compounds
EP4151627A1 (en) 2017-06-05 2023-03-22 PTC Therapeutics, Inc. Compounds for treating huntington's disease
BR112020019373A2 (pt) 2018-03-27 2020-12-29 Ptc Therapeutics, Inc. Compostos para o tratamento da doença de hutington
KR20210038845A (ko) 2018-06-27 2021-04-08 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료를 위한 헤테로아릴 화합물
IL279688B2 (en) * 2018-06-27 2025-01-01 Ptc Therapeutics Inc Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease
WO2020161208A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
WO2020161209A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
CA3139821A1 (en) 2019-05-13 2020-11-19 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
EP4178580B1 (en) 2020-07-09 2025-11-05 Usher III Initiative, Inc. Bf 844 for use in the treatment of cancer
WO2023139091A1 (en) * 2022-01-19 2023-07-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Geralexin and uses thereof for the treatment of retinal degenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206723D0 (en) * 2002-03-21 2002-05-01 Glaxo Group Ltd Novel compounds
US20090306045A1 (en) * 2005-12-22 2009-12-10 Ira Mellman Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease
WO2009062118A2 (en) * 2007-11-07 2009-05-14 Foldrx Pharmaceuticals, Inc. Modulation of protein trafficking
JP5902293B2 (ja) * 2011-04-25 2016-04-13 アッシャー・サード・イニシアティブ・インコーポレイテッド ピラゾロピリダジンおよび網膜変性疾患およびアッシャー症候群に伴う聴覚損失を治療するための方法
JP6290910B2 (ja) * 2012-10-25 2018-03-07 アッシャー・サード・イニシアティブ・インコーポレイテッド ピラゾロピリダジンならびに網膜変性疾患およびアッシャー症候群に伴う聴力損失を処置するための方法

Also Published As

Publication number Publication date
AU2013334139B2 (en) 2017-08-03
EP2911671B1 (en) 2018-06-27
PL2911671T3 (pl) 2018-11-30
HK1214180A1 (en) 2016-07-22
CA2889494C (en) 2018-12-18
ZA201502655B (en) 2017-11-29
IL238288A0 (en) 2015-06-30
AU2013334139A1 (en) 2015-04-30
JP2015535257A (ja) 2015-12-10
EP2911671A4 (en) 2016-09-14
CA2889494A1 (en) 2014-05-01
ES2687854T3 (es) 2018-10-29
WO2014066836A1 (en) 2014-05-01
EP2911671A1 (en) 2015-09-02
HUE039970T2 (hu) 2019-02-28
JP6291502B2 (ja) 2018-03-14

Similar Documents

Publication Publication Date Title
ZA201502655B (en) Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
ZA201507790B (en) Enhanced adoptive cell therapy
IL234628A0 (en) Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
IL235826A0 (en) Diazaspirocycloalkane and azaspirocycloalkane
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
EP2839816A4 (en) LAYER UNIT AND EXTERNAL LAYER ENVELOPE
ZA201307961B (en) Pyrazolopyridazines and methods for treating retinal-degenarative diseases and hearing loss associated with usher syndrome
EP2907494A4 (en) TABLE FOR WHEELCHAIR AND WHEELCHAIR COMPRISING THE SAME
EP3061452A4 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
SG11201405418WA (en) Absorbent and absorbent article provided therewith
ZA201504405B (en) 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof
ZA201405392B (en) Substituted phenylimidazopyrazoles and use thereof
GB2508663B (en) Bedpan and bedpan support
GB201213782D0 (en) Process and dressing
ZA201502654B (en) Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
GB2504303B (en) Earphones and earplugs
GB201221092D0 (en) Assemblies and methods
GB201213778D0 (en) Process and dressng
IL243842A0 (en) Hydrogel fibers and methods for their preparation
AU2012901222A0 (en) Treatment and prophylaxis
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
HUE048382T2 (hu) 6-klór-3-(fenil-d5)-inden-1-on és alkalmazása
GB201211961D0 (en) Methods and groups

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed